Crowdonomics
WatchlistPortfolio
Neureka® for Epilepsy

Reg CF · SAFE · Feb 2023

ClosedReached targetReg CFSAFE
via Republic · last checked Oct 8, 2026View campaign
Raised
$87.1K / $1.2M max
7% of ceiling · target hit day 4
Investors
100
$871 avg
Valuation cap
$25M
cap, not an agreed valuation

Raised over time

Cumulative raisedInvestors
$91K$45K$0
97490
Feb 12, 2023 · openedApr 14, 2023 · last reading
Target ($25K) hit — Feb 16, 2023, day 4Deadline Apr 15, 2023 — 1 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via Republic, last checked Oct 8, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2020–FY2021 · hover for source
$0
−$962K
FY2020
$0
−$1.4M
FY2021
RevenueNet income
Metric
FY2020 reviewed
FY2021 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$962,316
-$1,393,497
Taxes paid
$0
$0
Balance sheet
Cash
$64,459
$281,299
Accounts receivable
$0
$0
Total assets
$71,179
$286,340
Short-term debt
$34,704
$50,065
Long-term debt
$42,167
$20,171
Total liabilities
$76,871
$70,236
Other
Headcount
—
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Valuation cap$25M

Perks

Invest $500, receive Neureka coffee & tea mug$500+

Offering details

Target$25,000
Max$1,235,000
Min investment$150
OpenedFeb 12, 2023
DeadlineApr 15, 2023
ClosedApr 15, 2023
Days active62

Links & provenance

Campaign pageSEC filing
Source: Manual
0001768586-23-000001
Last synced Aug 19, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.